News and Reports | May 29, 2026
The House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence and the Internet is scheduled to hold a hearing June 4 to discuss balancing innovation and access for medicines and intellectual property, according to the House Committee Repository.
Last week, Patients For Affordable Drugs Now, AARP, and The ERISA Industry Committee wrote to congressional leadership expressing support for the Eliminating Thickets toIncrease Competition Act, a bill that aims to address patent thicketing — a practice in which drugmakers create a system of multiple patents on one drug to delay generic competition.
“By limiting the number of patents a drug manufacturer can assert during litigation to one per patent family, this legislation preserves legitimate intellectual property protections while preventing abuse that keeps lower-cost options off the market,” the groups wrote.